Zurich Cantonal Bank
ASND icon

Zurich Cantonal Bank’s Ascendis Pharma A/S ASND Stock Holding History

Zurich Cantonal Bank’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56
Closed -$11.6K – 2629
2025
Q3 		$11.1K Sell
56
-27
-33% -$5.04K ﹤0.01% 2495
2025
Q2 		$14.3K Sell
83
-14
-14% -$2.28K ﹤0.01% 2498
2025
Q1 		$15.1K Sell
97
-16
-14% -$2.29K ﹤0.01% 2568
2024
Q4 		$15.6K Sell
113
-26
-19% -$3.42K ﹤0.01% 2598
2024
Q3 		$20.8K Hold
139
– – ﹤0.01% 2597
2024
Q2 		$19K Sell
139
-3
-2% -$408 ﹤0.01% 2592
2024
Q1 		$21.5K Buy
142
+32
+29% +$4.57K ﹤0.01% 2623
2023
Q4 		$13.9K Sell
110
-14
-11% -$1.4K ﹤0.01% 2669
2023
Q3 		$11.6K Sell
124
-41
-25% -$3.84K ﹤0.01% 2733
2023
Q2 		$14.7K Sell
165
-40
-20% -$3.48K ﹤0.01% 2736
2023
Q1 		$22K Buy
+205
New +$23.5K ﹤0.01% 2738
2022
Q3 		– Sell
-4,093
Closed -$380K – 2906
2022
Q2 		$380K Hold
4,093
– – ﹤0.01% 1394
2022
Q1 		$480K Hold
4,093
– – ﹤0.01% 1343
2021
Q4 		$551K Hold
4,093
– – ﹤0.01% 1368
2021
Q3 		$652K Hold
4,093
– – ﹤0.01% 1126
2021
Q2 		$538K Sell
4,093
-744
-15% -$99.1K ﹤0.01% 1192
2021
Q1 		$623K Hold
4,837
– – ﹤0.01% 1087
2020
Q4 		$807K Buy
4,837
+785
+19% +$130K ﹤0.01% 1044
2020
Q3 		$625K Hold
4,052
– – ﹤0.01% 992
2020
Q2 		$599K Buy
4,052
+1,267
+45% +$174K 0.01% 945
2020
Q1 		$314K Hold
2,785
– – ﹤0.01% 1020
2019
Q4 		$387K Buy
+2,785
New +$309K ﹤0.01% 995

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Zurich Cantonal Bank's ASND Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 56 shares — an estimated $11.6K sold.

Zurich Cantonal Bank first reported a position in ASND in Q4 2019 and held it in 22 quarters. The position peaked at $807K in Q4 2020. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 56 Ascendis Pharma A/S shares in Q4 2025, an estimated $11.6K.
  • Zurich Cantonal Bank first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 22 quarters.
  • Zurich Cantonal Bank's Ascendis Pharma A/S position peaked at $807K in Q4 2020.
  • 302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.